Literature DB >> 12364343

Regulation of TSC2 by 14-3-3 binding.

Yong Li1, Ken Inoki, Raymond Yeung, Kun-Liang Guan.   

Abstract

Mutation in either the TSC1 or TSC2 tumor suppressor gene is responsible for the inherited genetic disease of tuberous sclerosis complex. TSC1 and TSC2 form a physical and functional complex to regulate cell growth. Recently, it has been demonstrated that TSC1.TSC2 functions to inhibit ribosomal S6 kinase and negatively regulate cell size. TSC2 is negatively regulated by Akt phosphorylation. Here, we report that TSC2, but not TSC1, associates with 14-3-3 in vivo. Phosphorylation of Ser(1210) in TSC2 is required for its association with 14-3-3. Our data indicate that 14-3-3 association may inhibit the function of TSC2 and represents a possible mechanism of TSC2 regulation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12364343     DOI: 10.1074/jbc.C200510200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  32 in total

1.  Negative regulation of the RalGAP complex by 14-3-3.

Authors:  Dara Leto; Maeran Uhm; Anja Williams; Xiao-wei Chen; Alan R Saltiel
Journal:  J Biol Chem       Date:  2013-02-05       Impact factor: 5.157

2.  Identification of mechanically regulated phosphorylation sites on tuberin (TSC2) that control mechanistic target of rapamycin (mTOR) signaling.

Authors:  Brittany L Jacobs; Rachel M McNally; Kook-Joo Kim; Rocky Blanco; Rachel E Privett; Jae-Sung You; Troy A Hornberger
Journal:  J Biol Chem       Date:  2017-03-13       Impact factor: 5.157

3.  Increased expression of 14-3-3β promotes tumor progression and predicts extrahepatic metastasis and worse survival in hepatocellular carcinoma.

Authors:  Tzu-An Liu; Yee-Jee Jan; Bor-Sheng Ko; Shyh-Chang Chen; Shu-Man Liang; Ya-Lin Hung; Chiun Hsu; Tang-Long Shen; Yen-Ming Lee; Pei-Feng Chen; John Wang; Song-Kun Shyue; Jun-Yang Liou
Journal:  Am J Pathol       Date:  2011-10-01       Impact factor: 4.307

Review 4.  mTOR: from growth signal integration to cancer, diabetes and ageing.

Authors:  Roberto Zoncu; Alejo Efeyan; David M Sabatini
Journal:  Nat Rev Mol Cell Biol       Date:  2010-12-15       Impact factor: 94.444

5.  Mechanism of Akt1 inhibition of breast cancer cell invasion reveals a protumorigenic role for TSC2.

Authors:  Hong Liu; Derek C Radisky; Celeste M Nelson; Hui Zhang; Jimmie E Fata; Richard A Roth; Mina J Bissell
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-07       Impact factor: 11.205

6.  Biochemical and functional characterizations of small GTPase Rheb and TSC2 GAP activity.

Authors:  Yong Li; Ken Inoki; Kun-Liang Guan
Journal:  Mol Cell Biol       Date:  2004-09       Impact factor: 4.272

7.  REDD1 enhances protein phosphatase 2A-mediated dephosphorylation of Akt to repress mTORC1 signaling.

Authors:  Michael D Dennis; Catherine S Coleman; Arthur Berg; Leonard S Jefferson; Scot R Kimball
Journal:  Sci Signal       Date:  2014-07-22       Impact factor: 8.192

8.  Akt1 governs breast cancer progression in vivo.

Authors:  Xiaoming Ju; Sanjay Katiyar; Chenguang Wang; Manran Liu; Xuanmao Jiao; Shengwen Li; Jie Zhou; Jacob Turner; Michael P Lisanti; Robert G Russell; Susette C Mueller; John Ojeifo; William S Chen; Nissim Hay; Richard G Pestell
Journal:  Proc Natl Acad Sci U S A       Date:  2007-04-25       Impact factor: 11.205

9.  Hypoxia induces permeability and giant cell responses of Andes virus-infected pulmonary endothelial cells by activating the mTOR-S6K signaling pathway.

Authors:  Irina N Gavrilovskaya; Elena E Gorbunova; Erich R Mackow
Journal:  J Virol       Date:  2013-09-25       Impact factor: 5.103

10.  Differential 14-3-3 affinity capture reveals new downstream targets of phosphatidylinositol 3-kinase signaling.

Authors:  Fanny Dubois; Franck Vandermoere; Aurélie Gernez; Jane Murphy; Rachel Toth; Shuai Chen; Kathryn M Geraghty; Nick A Morrice; Carol MacKintosh
Journal:  Mol Cell Proteomics       Date:  2009-08-01       Impact factor: 5.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.